This was the stock's second consecutive day of gains.

EST Ocugen (OCGN) files to sell 57.54M shares of common stock for holdersInvest with Confidence: Follow TipRanks' Top Wall Street ...

This was the stock's second consecutive day of losses.

Ocugen Inc (OCGN) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.05 or -6.41% from the prior close of $0.78. The stock opened at $0.78 and touched a low of $0.71 ...

OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clinical trial is anticipated to start in ...

Ocugen, Inc. announced that the FDA has approved its Investigational New Drug application for OCU500, a mucosal vaccine for COVID-19, which will be delivered via inhalation and as a nasal spray.

Ocugen (OCGN) announced that the U.S. FDA has reviewed the company’s Investigational New Drug application and it is in effect. This is a ...

On Friday, Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.78 which represents no change from the prior close of of $0.78. The stock opened at $0.79 and touched a low of $0.77 during ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies ...

At close: 14 November at 4:00 pm GMT-5 ...